Items Tagged ‘Skin Cancer’

October 11th, 2016

Epacadostat Plus Keytruda® Appears Effective in Melanoma

By

The treatment combination consisting of epacadostat plus Keytruda® (pembrolizumab) appears effective in the treatment of advanced melanoma. Melanoma is a type of skin cancer that often starts in the form of a mole. If detected and treatable with surgery, melanoma has a high cure rate. However, once melanoma invades deeper tissues or spreads from its […]

View full entry

Tags: advanced, Epacadostat, keytruda, Melanoma, mole, News, Skin Cancer, Stage III Melanoma, Stage IV Melanoma


June 14th, 2016

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma

By

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these hard to treat cancers. Merkel cell carcinoma is a rare aggressive skin cancer with limited treatment options for […]

View full entry

Tags: General Skin Cancer, keytruda, Merkel cell carcinoma, News, pembrolizumab, Skin Cancer


December 2nd, 2015

Opdivo Receives Expanded Approval as Single Agent for Initial Therapy in Melanoma

By

The United States Food and Drug Administration (FDA) has approved the PD1 inhibitor, Opdivo (nivolumab), as a single agent for initial therapy of advanced melanoma. This is the sixth indication for which Opdivo has been approved in the past 12 months. The indication for this expanded approval specifies that Opdivo can be used for treatment […]

View full entry

Tags: advanced, CheckMate -066 trial, Melanoma, metastatic, News, opdivo, Skin Cancer, Stage III Melanoma, Stage IV Melanoma


November 12th, 2015

National “Check Yourself to Protect Yourself ALL YEAR” Campaign Highlights Need for Year-Round Skin Cancer Prevention

By

Although one in five Americans will get skin cancer in their lifetimes, 65 percent of people of color don’t believe they are at risk and face lower survival rates as a result. To change these odds, the cancer organization Patients Rising will use the November timeframe – when most people are not thinking about the […]

View full entry

Tags: campaign, cancer screening, early detection, General Skin Cancer, News, Skin Cancer


October 21st, 2015

Patients with Multiple Squamous Cell Carcinomas Should be Frequently Monitored

By

Patients with multiple sites of cutaneous squamous cell carcinoma (a type of skin cancer) have a significantly increased risk of developing a recurrence or spread to their lymph nodes, warranting frequent follow-up visits to their dermatologist. These results were recently published in the Journal of the American Medical Association (JAMA): Dermatology. Cutaneous squamous cell carcinoma […]

View full entry

Tags: CSCC, cutaneous squamous cell carcinoma, General Skin Cancer, News, recurrence, Skin Cancer


August 13th, 2015

Food and Drug Administration approves Odomzo for treatment of basal cell carcinoma

By

The U. S. Food and Drug Administration approved Odomzo® (sonidegib, formerly LDE225) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. The approval was based on demonstration of a durable objective response rate […]

View full entry

Tags: basal cell carcinoma, General Skin Cancer, News, odomzo, Skin Cancer


December 3rd, 2014

New Treatment Options Emerging For Advanced Basal Cell Carcinoma

By

Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types of local treatment and are not life threatening. In the most severe cases, the cancer may be very large, may invade structures other than the skin, or may spread to other parts of […]

View full entry

Tags: basal cell carcinoma, everidge, General Skin Cancer, mohs, News, Skin Cancer, vismodegib


November 14th, 2014

Progress in the Treatment of Advanced Melanoma and Other Skin Cancers

By

By one estimate, over the past three decades more people in the United States have had skin cancer than all other cancers combined.1 According to the American Cancer Society, 3.5 million cases of basal and squamous cell skin cancer are diagnosed each year.2 Rates of melanoma—the deadliest form of skin cancer—are on the rise,2 particularly […]

View full entry

Tags: anti-PD-1, basal cell, General Skin Cancer, keytruda, Melanoma, News, pembrolizumab, Recurrent Melanoma, Skin Cancer, Skin Cancer Overview, Stage III Melanoma, Stage IV Melanoma


June 13th, 2014

Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial

By

An experimental drug sonidegib (LDE225) appears to markedly shrink tumors in patients with advanced basal cell carcinoma according to results recently presented at the 2014 annual meeting of the American Society of Clinical Oncology.1 Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types […]

View full entry

Tags: asco, basal cell cancer, basal cell carcinoma, bcc, General Skin Cancer, LDE225, News, Skin Cancer, sonidegib


September 16th, 2013

End-of-Life Care Remains Aggressive, Despite Patient Wishes

By

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive intensive treatment until the last month of life and hospice care is often delayed until the final three […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, HIV Related Cancers


June 28th, 2013

Surgery May Not Be Best in Elderly Patients with Nonfatal Skin Cancer

By

Although skin cancer is often treated with surgery, older patients with a limited life expectancy may not benefit from this treatment approach because they may endure complications and not live long enough to benefit from the treatment, according to the results of a study published in JAMA Internal Medicine. Skin cancer is the most commonly […]

View full entry

Tags: General Skin Cancer, News, Skin Cancer, Skin Cancer Overview


June 19th, 2013

Some Squamous Cell Skin Cancers Are Deadly

By

Cutaneous squamous cell carcinoma is usually easily treated with surgery; however, a subsection of patients with specific disease risk factors are more likely to develop metastases and die from the disease, according to the results of a study published in JAMA Dermatology. Squamous cell carcinoma accounts for roughly 20% of all cases of non-melanoma skin cancer. […]

View full entry

Tags: General Skin Cancer, News, Skin Cancer


May 15th, 2013

Following Lifestyle Recommendations Reduces Risk of Cancer Death

By

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent reduced risk of dying from cancer compared to people who don’t follow the recommendations, […]

View full entry

Tags: Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, General, Head and Neck Cancer, HIV Related Cancers


February 11th, 2013

Cancer Deaths on the Decline

By

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence rates for both sexes combined decreased by 1.5 percent per year from 2000 to 2009 and […]

View full entry

Tags: Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, General, Head and Neck Cancer, HIV Related Cancers


July 11th, 2012

Coffee Might Reduce the Risk of Basal Cell Carcinoma

By

Good news for coffee lovers—drinking caffeinated coffee could lower the risk of developing basal cell carcinoma, according to the results of a study published in Cancer Research. The Harvard study found that increased caffeine intake was associated with a decreased risk of the common skin cancer. Basal cell carcinoma (BCC) is the most common type […]

View full entry

Tags: General Skin Cancer, News, Skin Cancer